Asian Journal of Medical Principles and Clinical Practice

Effectiveness of Intravenous Iron Therapy in Patients with Iron Deficiency Anemia Presented to Emergency Department; Retrospective Study

Muqbil Sayer Alshammari

Saudi Board of Emergency Medicine, King Salman Specialist Hospital, Hail, Saudi Arabia.

Ahmed Almutairi

King Khalid Hospital, Majmaah, Riyadh, Saudi Arabia.

Faridah Khalaf Awadh Alharbi

Alqassim University, Buraydah, Saudi Arabia.

*Author to whom correspondence should be addressed.

---

Abstract

Background: Patients admitted to the Emergency Department (ED) frequently with moderate to severe iron deficiency anemia (IDA). Our goal was to investigate the safety, side effects, and results of parenteral iron treatment for IDA patients presented to HMG ALRYAN hospital in Riyadh's emergency room.

Materials and Methods: This is a retrospective study, conducted in emergency department of HMG ALRYAN hospital Riyadh, among adult IDA patients presented to emergency department for IV iron therapy. The data was collected by authors from hospital electronic database, then entered and analysed using SPSS v 24.

Results: A total of 296 iron deficiency patients were included, their mean age was 35.3 ± 11.2. Females constitute 94.6% of study sample. Mean of baseline hemoglobin concentration was 10.6 ± 1.9. 1/12 later hemoglobin concentration mean was 12.2 ± 1.6. The baseline serum iron concentration ranged from 1 - 155.1 mcg/dL, with mean ± SD of 9.5 ± 16.1. The results showed a significant association between age regarding baseline serum iron concentration, and 1/12 later serum iron concentration, where the younger age ones had higher response to iron. The statistical analysis showed a significant association between adverse effect, and admission to hospital for adverse effect (P=0.003), where most of those who hadn’t adverse effects were D/C.

Conclusion: Among included patients 5.4% had adverse effects to IV iron to treat IDA. The younger age patients had a significantly higher response to IV iron therapy.

Keywords: Emergency Department (ED), Intravenous (I.V), Iron Deficiency Anemia (IDA), Adverse Effects (AEs)

---

---

---

References

Le CHH. The Prevalence of Anemia and Moderate-Severe Anemia in the US Population (NHANES 2003-2012). Collins JF, editor. PLoS One. 2016;11(11): e0166635.

Girelli D, Marchi G, Camaschella C. Anemia in the Elderly. HemaSphere. 2018;2(3):e40.

Gupta P, Perrine C, Mei Z, Scanlon K. Iron, Anemia, and Iron Deficiency Anemia among Young Children in the United States. Nutrients. 2016;8(6): 330.

Beverina I, Brando B. Prevalence of anemia and therapeutic behavior in the emergency department at a tertiary care Hospital: Are patient blood management principles applied? Transfus Apher Sci. 2019;58(5):688–92.

Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014 Jan 30;123(5):615–24.

Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmén J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant. 2006;21(2):378–82.

Boone S, Powers JM, Goodgame B, Peacock WF. Identification and Management of Iron Deficiency Anemia in the Emergency Department. J Emerg Med. 2019;57(5):637–45.

Goodnough LT. Iron deficiency syndromes and iron‐restricted erythropoiesis (CME). Transfusion. 2012;52(7):1584–92.

Executive Summary. Am J Kidney Dis. 2006;47:S11–5.

Auerbach M, Adamson J, Bircher A, Breymann C, Fishbane S, Gafter-Gvili A, et al. On the safety of intravenous iron, evidence trumps conjecture. Haematologica. 2015;100(5):e214–5.

Aksan A, Işık H, Radeke HH, Dignass A, Stein J. Systematic review with network meta‐analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017;45(10):1303–18.

Muñoz M, Stensballe J, Ducloy-Bouthors A-S, Bonnet M-P, De Robertis E, Fornet I, et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus. 2019;17(2):112–36.

Lewkowitz AK, Gupta A, Simon L, Sabol BA, Stoll C, Cooke E, et al. Intravenous compared with oral iron for the treatment of iron-deficiency anemia in pregnancy: A systematic review and meta-analysis. J Perinatol. 2019;39(4):519–32.

Anker SD, Kirwan B-A, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F, et al. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail. 2018;20(1):125–33.

Quintana-Díaz M, Fabra-Cadenas S, Gómez-Ramírez S, Martínez-Virto A, García-Erce JA, Muñoz M. A fast-track anaemia clinic in the Emergency Department: feasibility and efficacy of intravenous iron administration for treating sub-acute iron deficiency anaemia. Blood Transfus. 2016;14(2):126–33.

Díaz MQ, Borobia AM, García Erce JA, Maroun-Eid C, Fabra S, Carcas A, et al. Appropriate use of red blood cell transfusion in emergency departments: a study in five emergency departments. Blood Transfus. 2017;15(3):199–206.

Khadadah F, Callum J, Shelton D, Lin Y. Improving quality of care for patients with iron deficiency anemia presenting to the emergency department. Transfusion. 2018;58(8):1902–8.

Beverina I, Razionale G, Ranzini M, Aloni A, Finazzi S, Brando B. Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. Blood Transfus. 2020;18(2):106–16.

Spradbrow J, Lin Y, Shelton D, Callum J. Iron deficiency anemia in the emergency department: over-utilization of red blood cell transfusion and infrequent use of iron supplementation. CJEM. 2017 May 7;19(3):167–74.

Röhrig G, Klossok W, Becker I, Benzing T, Schulz RJ. Prevalence of anemia among elderly patients in an emergency room setting. Eur Geriatr Med. 2014;5(1):3–7.

Arastu AH, Elstrott BK, Martens KL, Cohen JL, Oakes MH, Rub ZT, et al. Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions. JAMA Netw Open. 2022;5(3):e224488.

Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104 (8):2263–8.

Patel K V. Epidemiology of anemia in older adults. Semin Hematol. 2008;45(4): 210–7.

Alsaeed M, Ahmed SS, Seyadi K, Ahmed AJ, Alawi AS, Abulsaad K. The prevalence and impact of anemia in hospitalized older adults: A single center experience from Bahrain. J Taibah Univ Med Sci. 2022;17 (4):587–95.